Update: Friday, 08 February 2013
Healthcare Growth Capital Conference will be held on April 11, 2013, at the W Hotel in New York City. The conference is being co-sponsored by Galen Partners, a leading growth equity firm focused solely on the healthcare industry, and International Business Forum, a world-class media and event production company.
The conference is designed as a forum for the exchange of strategies on growing existing healthcare businesses to scale and providing expansion capital to high-growth companies with revenues of ten million to hundreds of millions of dollars. Conference attendees will include CEOs and senior managers of high-growth healthcare companies, corporate business development executives and private equity investors.
“Growth capital investing in the healthcare sector has driven industry transformation, while providing investors with superior returns,” said Conference Chairman and Galen Managing Partner, Zubeen Shroff, who has over twenty years of experience in building healthcare companies. “Galen’s well-established track record of leading healthcare growth investments made us a natural partner to work with International Business Forum in developing what we expect to be a powerful forum for uniting key industry participants.”
Mr. Shroff is supported in the development of this high caliber program by an accomplished Board of Advisors which includes:
Managing Director, Bain Capital Ventures
Managing Director, Great Point Partners
Partner, SV Life Sciences
Partner, North Bridge
General Partner, Frazier Healthcare
Associate, Goldman Sachs Merchant Banking
Managing Director, Altaris
Principal, Baird Capital
Partner, Quaker Partners
Managing Director, OrbiMed
Managing Director, H.I.G. BioVentures
Key themes to be addressed at the inaugural meeting include: Defining the boundaries of success for growth investing; how chaos in Washington will affect healthcare companies and create investment opportunities; building service platforms of scale for the new healthcare economy; the evolution of specialty pharma and diagnostics; maximizing milestone and escrow collection post-transaction; cultivating rapid growth for emerging medical device companies; non-dilutive financing strategies for growth stage companies; digitizing the American healthcare system; and risk adjustment and assessment in the payor universe.
For more information on this unique event and to sign up to participate, visitwww.growthcapcon.com.
International Business Forum
Chief Strategy Officer